Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04761744
Status:
UNKNOWN
Last Update Posted:
2021-02-21
First Post:
2021-02-16
Brief Title:
A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers
Sponsor:
Korean Cancer Study Group
Organization:
Korean Cancer Study Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-16
First Submit QC Date:
February 16 2021
Study First Post Date:
2021-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-16
Last Update Post Date:
2021-02-21
Last Update Post Date Type:
ACTUAL